These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 8073367)

  • 1. Effects of the class III antiarrhythmic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos, in vitro.
    Spence SG; Vetter C; Hoe CM
    Teratology; 1994 Apr; 49(4):282-92. PubMed ID: 8073367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo.
    Ritchie HE; Ababneh DH; Oakes DJ; Power CA; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2013 Apr; 98(2):144-53. PubMed ID: 23504928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity.
    Webster WS; Brown-Woodman PD; Snow MD; Danielsson BR
    Teratology; 1996 Mar; 53(3):168-75. PubMed ID: 8761884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Dofetilide on the Heart Rate of GD11 and GD13 Rat Embryos, in vivo, Using Ultrasound.
    Ritchie H; Oakes D; Hung TT; Hegedus E; Sood S; Webster W
    Birth Defects Res B Dev Reprod Toxicol; 2015 Oct; 104(5):196-203. PubMed ID: 26401846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation.
    Danielsson BR; Azarbayjani F; Sköld AC; Webster WS
    Teratology; 1997 Oct; 56(4):271-81. PubMed ID: 9408978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.
    Danielsson BR; Skold AC; Azarbayjani F
    Curr Pharm Des; 2001 Jun; 7(9):787-802. PubMed ID: 11375779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media.
    Ritchie HE; Svensson CH; Nilsson MF; Webster WS
    J Pharmacol Toxicol Methods; 2014; 70(3):276-82. PubMed ID: 25091319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant.
    Abrahamsson C; Palmer M; Ljung B; Duker G; Bäärnhielm C; Carlsson L; Danielsson B
    Cardiovasc Res; 1994 Mar; 28(3):337-44. PubMed ID: 8174153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dofetilide, a novel class III antiarrhythmic agent.
    Rasmussen HS; Allen MJ; Blackburn KJ; Butrous GS; Dalrymple HW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S96-105. PubMed ID: 1279316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect on rat embryonic heart rate of Na+, K+, and Ca2+ channel blockers, and the human teratogen phenytoin, changes with gestational age.
    Nilsson MF; Ritchie H; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):416-27. PubMed ID: 24323366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499.
    Baskin EP; Lynch JJ
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):199-208. PubMed ID: 7526051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of dofetilide overdose in a patient with known cocaine abuse.
    Campbell KB; Mando JD; Gray AL; Robinson E
    Pharmacotherapy; 2007 Mar; 27(3):459-63. PubMed ID: 17316157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs cause bradycardia in GD 13 rat embryos in vitro.
    Gunnström M; Ababneh D; Webster WS; Oakes D; Ritchie H
    Reprod Toxicol; 2012 Nov; 34(3):443-50. PubMed ID: 22750488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental toxicity of the class III antiarrhythmic agent almokalant in mice. Adverse effects mediated via induction of embryonic heart rhythm abnormalities.
    Sköld AC; Danielsson BR
    Arzneimittelforschung; 2000 Jun; 50(6):520-5. PubMed ID: 10918943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs.
    Danielsson BR; Danielsson C; Nilsson MF
    Reprod Toxicol; 2007 Jul; 24(1):42-56. PubMed ID: 17570632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryotoxic effects of L-691,121, a class III antiarrhythmic agent, in rats.
    Ban Y; Konishi R; Kawana K; Nakatsuka T; Fujii T; Manson JM
    Arch Toxicol; 1994; 69(1):65-71. PubMed ID: 7717857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term programming effects on blood pressure following gestational exposure to the I
    Prestipino L; Polson JW; Brolin E; Ritchie HE
    Physiol Rep; 2018 Mar; 6(5):. PubMed ID: 29504284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of drugs with ion channel-blocking activity on the early embryonic rat heart.
    Abela D; Ritchie H; Ababneh D; Gavin C; Nilsson MF; Khan MK; Carlsson K; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):429-40. PubMed ID: 20973055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats.
    Danielsson B; Sköld AC; Azarbayjani F; Ohman I; Webster W
    Toxicol Appl Pharmacol; 2000 Mar; 163(2):164-75. PubMed ID: 10698674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hypoxia in development.
    Webster WS; Abela D
    Birth Defects Res C Embryo Today; 2007 Sep; 81(3):215-28. PubMed ID: 17963271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.